Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07530250 · ClinicalTrials.gov registry record · NA
Assessing Two Coenzyme Q10 Products in Men and Women
A NA study, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT07530250 is a NA study that is actively recruiting participants, run by Midwest Center for Metabolic and Cardiovascular Research. The registered enrollment target is 24 participants.
The verdict
NCT07530250, a NA study, is actively recruiting participants, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to compare the relative bioavailability of coenzyme Q10 (CoQ10) from acute administrations of a CoQ10 product designed for enhanced absorption versus a standard CoQ10 product in healthy men and women. Participants will be asked to come to the clinical on five different occasions, including a screening visit (visit 1, -7 days), two test 1 visits (visits 2 and 3, days 0 and 1), and two test 2 visits (visits 4 and 5, days 7 and 8). During the start of each test visit (visits 2 and 4), the participant will consume each study product with water and a standardized breakfast meal. Then, blood samples will be collected over a 10-hour period, and a standardized lunch, dinner, and snacks will be provided. The participant will return to the clinic the next morning for a blood draw 24 hours after the study product ingestion from the previous day. The same procedures will be repeated 7 to 14 days later with the other study product.
Interventions
- DIETARY_SUPPLEMENT high absorption CoQ10 product
- DIETARY_SUPPLEMENT standard CoQ10 product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-05-18 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07530250
The ClinicalTrials.gov registry entry for NCT07530250 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Midwest Center for Metabolic and Cardiovascular Research, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which high absorption CoQ10 product is the first listed.
NCT07530250 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07530250 about?
NCT07530250 is a clinical study titled "Assessing Two Coenzyme Q10 Products in Men and Women". The goal of this clinical trial is to compare the relative bioavailability of coenzyme Q10 (CoQ10) from acute administrations of a CoQ10 product designed for enhanced absorption versus a standard CoQ10 product in healthy men and women. Participants will be asked to come to the clinical on five diffe...
What is the current status of trial NCT07530250?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2026-05-18. Estimated completion is 2026-07.
What interventions are being tested in trial NCT07530250?
The interventions under investigation include: high absorption CoQ10 product (DIETARY_SUPPLEMENT), standard CoQ10 product (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07530250?
This trial is sponsored by Midwest Center for Metabolic and Cardiovascular Research, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.